Hong Kong orders Sinovac, Pfizer/BioNTech vaccines for first quarter

HONG KONG (HONG KONG) – Hong Kong has ordered 15 million doses of COVID-19 vaccine, which would be divided between China’s Sinovac Biotech Ltd. and Pfizer/BioNTech, twice the number of its residents, as told by the city’s leader, Carrie Lam, on Friday.

The first batch of 1 million will come from China in January, while another million from Pfizer/BioNTech is likely to arrive in the first quarter of next year.

The government plans for 30 million doses in total, as each person needs two injections to be fully vaccinated, and is also in talks to purchase the Oxford/AstraZeneca vaccine. The latter is expected to arrive in the second half of next year.

Lam said priority will be given to the elderly and other vulnerable categories.

Exit mobile version